EUVIMEDEUVIMED entdecken
Crossref

Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation

Vignesh Gunasekaran iD, Soowan Woo iD, Abhay Kumar Lodha, Atul Malhotra, Parvesh Mohan Garg

American Journal of Perinatology · 07.07.2026

DOI: 10.1055/a-2905-4174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 07.07.2026. Verfasst von Vignesh Gunasekaran und 4 weiteren Autor:innen. Beteiligte Einrichtung: West Virginia University School of Medicine, Department of Pediatrics, West Virginia, United States, Martinsburg. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: Parvesh Garg is partially supported by the NIGMS of the NIH, P.M.G. is partially supported by the NIGMS of the NIH., A.M.'s current research is supported by NHMRC and MRFF (Australia), Cerebral Palsy Alliance, National Stem Cell Foundation of Australia, Monash Health Foundati….

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Necrotizing enterocolitis (NEC) remains one of the most devastating gastrointestinal diseases of prematurity, carrying high mortality and long-term morbidity with no targeted disease-modifying therapy currently available. This review synthesizes preclinical and translational evidence for stem cell- and extracellular vesicle (EV)-based regenerative therapies in NEC and identifies the critical steps required for clinical translation. A narrative review of preclinical studies, systematic reviews, meta-analyses, and early-phase clinical trial data evaluating stem cell-based and cell-free EV therapies for NEC was performed. Evidence was organized across cell populations, mesenchymal stem cells (MSCs), amniotic fluid stem cells (AFSCs), placental-derived stem cells, and neural stem cells, and their derived EVs and exosomes, with synthesis of mechanistic, translational, safety, and ethical considerations. Multiple stem cell types consistently reduce NEC incidence, severity, and mortality in experimental models. Protective effects are mediated through epithelial regeneration, barrier reinforcement, Wnt/β-catenin pathway activation, immunomodulation, and angiogenesis. Cell-free strategies using MSC- and AFSC-derived EVs reproduce comparable benefits with a more favorable manufacturing and safety profile. Early-phase clinical trials of MSCs in other neonatal conditions confirm short-term tolerability, though no NEC-specific stem cell or EV trial has been completed. Regenerative cell and cell-free therapies represent a compelling disease-modifying strategy for NEC. Advancing this field requires standardized cell and EV characterization, optimized dosing and delivery protocols, large-animal model validation, and rigorously designed early-phase clinical trials with careful attention to safety, ethics, and regulatory frameworks.

Autor:innen und Institutionen

  • West Virginia University School of Medicine, Department of Pediatrics, West Virginia, United States, Martinsburg.
  • SUNY Downstate Health Sciences University, Department of Pediatrics, New York, United States, New York City.
  • University of Calgary Cumming School of Medicine, Department of Pediatrics, Canada, Calgary.
  • Monash University, Department of Paediatrics, Victoria, Australia, Melbourne.
  • Monash Newborn, Monash Children's Hospital, Victoria, Australia, Clayton.
  • The Ritchie Centre, Hudson Institute of Medical Research, Victoria, Australia, Clayton.

ORCID-Profile: Vignesh Gunasekaran, Soowan Woo

Förderung

  • Parvesh Garg is partially supported by the NIGMS of the NIH
  • P.M.G. is partially supported by the NIGMS of the NIH.
  • A.M.'s current research is supported by NHMRC and MRFF (Australia), Cerebral Palsy Alliance, National Stem Cell Foundation of Australia, Monash Health Foundati…

Zitieren

APA

Gunasekaran, V., Woo, S., Lodha, A. K., Malhotra, A., & Garg, P. M. (2026). Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation. American Journal of Perinatology. https://doi.org/10.1055/a-2905-4174

Vancouver

Gunasekaran V, Woo S, Lodha AK, Malhotra A, Garg PM. Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation. American Journal of Perinatology. 2026. doi:10.1055/a-2905-4174

BibTeX
@article{Gunasekaran2026,
  author = {Gunasekaran, Vignesh and Woo, Soowan and Lodha, Abhay Kumar and Malhotra, Atul and Garg, Parvesh Mohan},
  title = {Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation},
  journal = {American Journal of Perinatology},
  year = {2026},
  doi = {10.1055/a-2905-4174}
}
Kostenlos starten →